SCHEMBL679010

SCHEMBL679010

Cc1ccccc1C(=O)Nc1ccc(N)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.74
SMN1; SMN2 Q16637 6/20 0.73
ALDH1A1 P00352 4/20 0.69
NPC1 O15118 6/20 0.67
RAB9A P51151 6/20 0.67
TYK2 P29597 1/20 0.66
FFAR1 O14842 1/20 0.63
MAPT P10636 3/20 0.61
LMNA P02545 2/20 0.61
THRB P10828 1/20 0.61
GAA P10253 4/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
TDP1 Q9NUW8 2/20 0.58
MAPK1 P28482 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
HTT P42858 1/20 0.57
DHODH Q02127 1/20 0.56
KCNK3 O14649 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8402954 0.87 KMT2A (0.64) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL3684485 0.86 HPGD (0.79) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL29519361 0.86 HPGD (0.79) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL21993 0.85 HPGD (1.00) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL11781486 0.84 HPGD (0.77) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL3717639 0.84 ALDH1A1 (0.64) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL17660206 0.83 HPGD (0.70) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL3468940 0.83 HPGD (0.74) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL10427105 0.83 KMT2A (0.59) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL19501494 0.83 HPGD (0.86) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269758-A1 NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS MERCK PATENT GMBH (DE) 2011-11-03 US claimed
JP-2011526912-A 2011-10-20 JP claimed
EP-2291376-A2 NAPHTHYRIDININONES AS AURORA KINASE INHIBITORS Merck Patent GmbH (DE) 2011-03-09 EP claimed
WO-2010002779-A2 NAPHTHYRIDININONES AS AURORA KINASE INHIBITORS MERCK SERONO S.A. (CH) 2010-01-07 WO claimed
CN-101336244-B 9-membered heterobicyclic compounds useful as protein kinase inhibitors ABBOTT LABORATORIES (US) 2011-11-30 CN disclosed
US-20110269758-A1 NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS MERCK PATENT GMBH (DE) 2011-11-03 US disclosed
EP-2291376-A2 NAPHTHYRIDININONES AS AURORA KINASE INHIBITORS Merck Patent GmbH (DE) 2011-03-09 EP disclosed
WO-2010002779-A2 NAPHTHYRIDININONES AS AURORA KINASE INHIBITORS MERCK SERONO S.A. (CH) 2010-01-07 WO disclosed
CN-101336244-A 9-membered heterobicyclic compounds useful as protein kinase inhibitors ABBOTT LAB (US) 2008-12-31 CN disclosed
EP-1968979-A2 9-MEMBERED HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PROTEIN KINASES ABBOTT LABORATORIES (US) 2008-09-17 EP disclosed
WO-2007067781-A2 9-MEMBERED HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PROTEIN KINASES ABBOTT LABORATORIES (US) 2007-06-14 WO disclosed
US-20070135387-A1 Inhibitors of protein kinases ABBOTT LABORATORIES 2007-06-14 US disclosed
US-6197803-B1 VIRICIDES; PREVENTION REPRODUCTION AMERICAN HOME PRODUCTS CORPORATION 2001-03-06 US disclosed
US-6166028-A Diaminopuridine-containing thiourea inhibitors of herpes viruses AMERICAN HOME PRODUCTS CORPORATION (US) 2000-12-26 US disclosed
WO-2000034238-A1 THIOUREA INHIBITORS OF HERPES VIRUSES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed
WO-2000034260-A2 ALPHA-METHYLBENZYL-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A PHENYLENEDIAMINE GROUP AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed
WO-2000034261-A2 HETEROCYCLIC CARBOXAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING A SUBSTITUTED PHENYLENEDIAMINE GROUP AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed
WO-2000034269-A1 THIOUREA INHIBITORS OF HERPES VIRUSES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed
WO-2000034237-A2 ACETAMIDE AND SUBSTITUTED ACETAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed
WO-2000034258-A2 HETEROCYCLIC CARBOXAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES CONTAINING PHENYLENEDIAMINE GROUP AMERICAN HOME PRODUCTS CORPORATION (US) 2000-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269758-A1 NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS AURKA, AURKC, AURKB HPGD 2277/4885SMN1; SMN2 4355/4885ALDH1A1 4078/4885
US-20070135387-A1 Inhibitors of protein kinases MAP3K20, PACSIN2, MAP4K2 HPGD 1820/4885SMN1; SMN2 2618/4885ALDH1A1 4438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.